'Illumina faces a record fine from the EU as early as next week after the world’s biggest gene sequencing company bought Silicon Valley cancer screening start-up Grail for $8bn without Brussels’ approval.'

https://www.ft.com/content/1855b5a1-e4bc-4685-ae2d-0c32520da94b